Global Methylxanthines Market, By Source (Natural, Animals, Others), Product (Theophylline, Caffeine, Theobromine, Others), Indication (Asthma, Chronic Bronchitis, Emphysema, Chronic Obstructive Pulmonary Disease, Others), Activity (Immunomodulatory, Anti-inflammatory, Bronchoprotective, Bronchodilator, Stimulants, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029
Methylxanthines Market Analysis and Size
The global methylxanthines market is expected to witness significant growth during the forecast period. Rising prevalence of pulmonary diseases worldwide and emerging markets are the factors responsible for the growth of this market. Growing cases of asthma & COPD drives the methylxanthines market. In addition, advances in the treatment options and the presence of well-established healthcare facilities are some of the impacting factors for the growth of tinnitus market. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the global methylxanthines market in the forecast period 2022-2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Methylxanthines are alkaloid drugs derived from the purine base xanthine and can be found in high concentrations of tea, coffee and chocolate. They are widely used in the treatment of asthma, COPD, chronic bronchitis and emphysema. Caffeine, theobromine and theophylline are the most popular methylxanthines. In coffee, caffeine is the main methylxanthine, theobromine in chocolate, and theophylline is the primary methylxanthine in tea. Methylxanthines acts by elevating cAMP in airways smooth muscles owing to inhibiting the enzyme phosphodiesterase and antagonize adenosine receptors or systemic release of catecholamines.
Report Scope and Market Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2022 to 2029 |
|
Base Year |
2021 |
|
Historic Years |
2020 (Customizable to 2014 - 2019) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Source (Natural, Animals, Others), Product (Theophylline, Caffeine, Theobromine, Others), Indication (Asthma, Chronic Bronchitis, Emphysema, Chronic Obstructive Pulmonary Disease, Others), Activity (Immunomodulatory, Anti-inflammatory, Bronchoprotective, Bronchodilator, Stimulants, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) |
|
Countries Covered |
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America |
|
Market Players Covered |
Bayer AG (Germany), Teva Pharmaceutical Industries Ltd. (Israel), Sun Pharmaceutical Industries Ltd. (India), Hikma Pharmaceutical PLC (U.S.), Amneal Pharmaceuticals LLC. (U.S.), Aurobindo Pharma (India), Johnsons & Johnsons Private limited (U.S.) and GSK Plc (U.K.) |
|
Market Opportunities |
|
Global Methylxanthines Market Dynamics
Drivers
- Increase in COPD cases
According to WHO, COPD mainly occurs in the under developed countries. In addition to this, a study conducted in 2016 reported 251 million cases of COPD worldwide. Chronic obstructive pulmonary disease is categorised by the symptoms such as shortness of breath, wheezing, frequent coughing, tightness in the chest. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Increasing Drug Development and Research Activities
Technological advancements and rapid innovation in drug discovery and development especially in the field of personalized medicine create significant opportunities to the manufacturers in the global methylxanthines market. This is another factor expected to drive growth of the methylxanthines market.
- Increasing Demand for Retail Pharmacies
Rise in the number of drugs for tinnitus being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Side Effects of Methylxanthines
There are varied side-effects that are associated with methylxanthines. Side-effects such as nausea, increased gastric acid secretion, vomiting, polyuria, insomnia, headaches, palpitations, and tremors may hamper the growth of the market.
- High Cost
The huge expenditure associated with these agents surely hamper the market growth.
This global methylxanthines market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global methylxanthines market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Methylxanthines Market
Considering the present scenario, COVID-19 has left an unprecedented global public health crisis that has impacted practically every business. Its long-term repercussions are expected to influence industry growth during the forecast period. Transition of healthcare infrastructure toward managing COVID-19 has led to drug launch cancellations and delays in clinical trials.
In the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge future growth due to the demand for vaccine and treatment drugs for COVID-19. Thus, this will leave a significant impact on the global methylxanthines market.
Global Methylxanthines Market Scope
The global methylxanthines market is segmented on the basis of source, product, indication, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Source
- Natural
- Animals
- Others
Product
- Theophylline
- Caffeine
- Theobromine
- Others
Indication
- Asthma, Chronic Bronchitis
- Emphysema
- Chronic Obstructive Pulmonary Disease
- Others
Route of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Methylxanthines Market Regional Analysis/Insights
The global methylxanthines market is analysed and market size insights and trends are provided by source, product, indication, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the global methylxanthines market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Asia-Pacific has been witnessing a positive growth for global methylxanthines market throughout the forecasted period due to increased WHO & government awareness programs, industrialization, and pollution.
North America dominates the market due to pollution and change in lifestyle.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Methylxanthines Market Share Analysis
The global methylxanthines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to global methylxanthines market
Key players operating in the global methylxanthines market include:
- Bayer AG (Germany)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sun Pharmaceutical Industries Ltd. (India)
- Hikma Pharmaceutical PLC (U.S.)
- Amneal Pharmaceuticals LLC. (U.S.)
- Aurobindo Pharma (India)
- Johnsons & Johnsons Private limited (U.S.)
- GSK Plc (U.K.)
SKU-
